What Is|Charitable Organization|Richmond California|Curing Type 1 Diabetes
Become a part of us by visiting http://helpcurediabetes.jdrftypeone.com
Richmond is a city in western Contra Costa County, California, United States. The city was incorporated on August 7, 1905. Located in the eastern region of the San Francisco Bay Area, Richmond borders the cities of San Pablo, Albany, El Cerrito and Pinole in addition to the unincorporated communities of North Richmond, Hasford Heights, Kensington, El Sobrante, Bayview-Montalvin Manor, Tara Hills, and East Richmond Heights, and briefly San Francisco on Red Rock Island. Under the McLaughlin Administration, Richmond was the largest city in the United States served by a Green Party mayor. As of the 2010 U.S. Census, the city’s population is at 103,710, making it the second largest city in the United States to be named Richmond, after Richmond, Virginia. The name “Richmond” appears to predate actual incorporation by more than fifty years. Edmund Randolph, originally from Richmond, Virginia, represented the city of San Francisco when California’s first legislature met in San Jose in December 1849, and he became state assemblyman from San Francisco. His loyalty to the town of his birth caused him to persuade a federal surveying party mapping the San Francisco Bay to place the names “Point Richmond” and “Richmond” on an 1854 geodetic coast map, which was the geodetic map at the terminal selected by the San Francisco and San Joaquin Valley Railroad; and by 1899 maps made by the railroad carried the name “Point Richmond Avenue,” designating a county road that later became Barrett Avenue, a central street in Richmond. Media Credits Column http://broadcaster.beazil.net/public/credits/youtube/videos/121107 JDRF is the leading diabetes foundation funding T1D research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF collaborates with a wide spectrum of partners and is the only organization with the scientific resources, regulatory influence, and a working plan to better treat, prevent, and eventually cure T1D. JDRF is currently sponsoring $530 million in scientific research in 17 countries. In 2012 alone, JDRF provided more than $110 million to T1D research. JDRF’s goal is a world without type 1 diabetes (T1D). The Health Care and Social Assistance sector comprises establishments providing health care and social assistance for individuals. The sector includes both health care and social assistance because it is sometimes difficult to distinguish between the boundaries of these two activities. The industries in this sector are arranged on a continuum starting with those establishments providing medical care exclusively, continuing with those providing health care and social assistance, and finally finishing with those providing only social assistance. The services provided by establishments in this sector are delivered by trained professionals. All industries in the sector share this commonality of process, namely, labor inputs of health practitioners or social workers with the requisite expertise. Various types of insulin are used to treat diabetes and include: Rapid-acting insulin: It starts working approximately 15 minutes after injection and peaks at approximately 1 hour but continues to work for two to four hours. This is usually taken before a meal and in addition to a long-acting insulin. Short-acting insulin: It starts working approximately 30 minutes after injection and peaks at approximately 2 to 3 hours but will continue to work for three to six hours. It is usually given before a meal and in addition to a long-acting insulin. Intermediate-acting insulin: It starts working approximately 2 to 4 hours after injection and peaks approximately 4 to 12 hours later and continues to work for 12-18 hours. Type 1 diabetes is an auto-immune condition in which the immune system is activated to destroy the cells in the pancreas which produce insulin. We do not know what causes this auto-immune reaction. Type 1 diabetes is not linked to modifiable lifestyle factors. There is no cure and it cannot be prevented. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease ‘juvenile diabetes’ because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day. Thanks to better therapies—which JDRF funding has been instrumental in developing and making available—people with T1D live longer and stay healthier while they await the cure.
Get in touch with our Twitter account https://twitter.com/JDRFTypeOne The important points are: Rapid-acting insulin.